Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 66260

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 12, 2013
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Hospira Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 2

0.25% Bupivacaine HCl Injection, USP, 2.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1159-02

D-380-2014
Recall number
D-380-2014
Initiated
July 12, 2013
Classification
Class I
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
118,100 vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
particulate matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.

Code information

Lot # 18-136-DK; Exp. 6/14

Distribution pattern

Nationwide

drug · product 2 of 2

0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-02

D-381-2014
Recall number
D-381-2014
Initiated
July 12, 2013
Classification
Class I
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
119,600 vials

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
particulate matter

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.

Code information

Lot # 23-338-DK, Exp. 11/14

Distribution pattern

Nationwide